Loading…
Mineralys Therapeutics, Inc. is projected to rise to $32.75 by 2027, a +15% move from its current price of $28.38. MLYS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $27.57 | $28.41 | $29.28 | +0.10% |
| Jul 14 | $27.26 | $28.44 | $29.67 | +0.21% |
| Jul 15 | $27.03 | $28.47 | $29.99 | +0.31% |
| Jul 16 | $26.84 | $28.50 | $30.26 | +0.42% |
| Jul 17 | $26.67 | $28.53 | $30.51 | +0.53% |
| Jul 18 | $26.53 | $28.56 | $30.74 | +0.63% |
| Jul 19 | $26.40 | $28.59 | $30.96 | +0.74% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.40 | $28.59 | $30.96 | +0.74% |
| Week 2 | $25.74 | $28.80 | $32.23 | +1.48% |
| Week 3 | $25.28 | $29.01 | $33.30 | +2.23% |
| Week 4 | $24.93 | $29.23 | $34.26 | +2.98% |
| Week 5 | $24.64 | $29.44 | $35.17 | +3.74% |
| Week 6 | $24.41 | $29.66 | $36.03 | +4.50% |
| Week 7 | $24.21 | $29.88 | $36.87 | +5.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mineralys Therapeutics, Inc. is a biopharmaceutical company focused on diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea.
The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Mineralys Therapeutics (MLYS) currently trades at $29.12. It has a market capitalization of $2.57B and a rank of 1857. The price outlook, based on the provided forecasts, shows a path of growth from 2026 onward, with the 2026 average price at $29.12 and higher averages in later years (for example, 2030 avg $44.08, 2040 avg $115.24, and 2050 avg $257.50).
A major floor 35.0% below — a decisive break under it would weaken the trend.
The nearest floor, 20.7% below — buyers have tended to step in here.
The nearest ceiling, 11.1% above — a clean break opens room to run.
A major ceiling 28.7% above — clearing it would confirm fresh momentum.
Key MLYS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLYS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.46 | Sell | $28.88 | Sell |
| MA 10 | $28.24 | Buy | $28.28 | Buy |
| MA 20 | $26.54 | Buy | $27.50 | Buy |
| MA 50 | $27.38 | Buy | $27.32 | Buy |
| MA 100 | $27.29 | Buy | $28.07 | Buy |
| MA 200 | $32.45 | Sell | $28.01 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.84 | Neutral |
| Stoch RSI (14) | 39.89 | Neutral |
| CCI (20) | 71.98 | Neutral |
| Williams %R (14) | -40.86 | Info |
| MACD (12,26,9) | 0.43 | Buy |
| ROC (12) | 10.82 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 59.14 | Neutral |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | 2.46 | Buy |
| Ultimate (7,14,28) | 62.56 | Neutral |
| Momentum (10) | 2.04 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 30.08 | Sell |
| ADX (14) | 18.11 | Neutral |
| ATR (14) | 0.70 | Info |
The 30-day technical picture shows bullish tendencies with RSI14 at 70 and moving averages at $27.19 (SMA50) and $32.64 (SMA200).
Support is at $22.50 and resistance at $31.54, with a 30-day price range of $23.83 to $35.59.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $22.50 | $28.38 | $41.27 | 0% | Neutral | |
| $25.83 | $32.75 | $44.07 | +15% | Neutral | |
| $27.86 | $36.44 | $51.05 | +28% | Bullish | |
| $29.83 | $40.04 | $57.87 | +41% | Bullish | |
| $31.15 | $42.77 | $63.46 | +51% | Bullish | |
| $38.23 | $53.61 | $81.39 | +89% | Bullish | |
| $43.38 | $62.02 | $96.12 | +119% | Bullish | |
| $46.09 | $67.10 | $105.94 | +136% | Bullish | |
| $46.40 | $68.74 | $110.39 | +142% | Bullish | |
| $45.46 | $68.49 | $111.73 | +141% | Bullish | |
| $67.00 | $108.94 | $189.86 | +284% | Bullish | |
| $131.00 | $243.29 | $466.56 | +757% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $22.50 | $28.38 | $34.24 | +0.00% |
| August 2026 | $25.52 | $30.20 | $36.75 | +6.41% |
| September 2026 | $26.18 | $31.23 | $38.47 | +3.40% |
| October 2026 | $25.87 | $31.05 | $38.65 | -0.55% |
| November 2026 | $26.12 | $31.54 | $39.59 | +1.56% |
| December 2026 | $26.87 | $32.62 | $41.27 | +3.42% |
Click any year to see its month-by-month MLYS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, MLYS is projected to trade between $22.50 and $41.27, averaging $28.38 — a potential gain of 0% from today's $28.38. Price action looks broadly range-bound.
Mineralys Therapeutics, Inc.'s 2027 outlook centres on $32.75, within a $25.83 to $44.07 range. That is up +15% on the projected 2026 average. That marks a +15% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, MLYS could reach as high as $51.05, with a base case around $36.44 and support toward $27.86 — roughly +28% from $28.38. Momentum favours further upside here.
Expect MLYS to range from $29.83 to $57.87 through 2029. The $40.04 average target implies a +41% move from current prices. That is up +10% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The MLYS price prediction for 2030 points to an average of $42.77 (low $31.15, high $63.46) — a potential gain of +51% on today's $28.38. Momentum favours further upside here.
In 2031, MLYS is projected to trade between $38.23 and $81.39, averaging $53.61 — a potential gain of +89% from today's $28.38. That is up +25% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Mineralys Therapeutics, Inc.'s 2032 outlook centres on $62.02, within a $43.38 to $96.12 range. That is up +16% on the projected 2031 average. That marks a +119% change versus current levels. Momentum favours further upside here.
By 2033, MLYS could reach as high as $105.94, with a base case around $67.10 and support toward $46.09 — roughly +136% from $28.38. Buyers look set to stay in control over this stretch.
Expect MLYS to range from $46.40 to $110.39 through 2034. The $68.74 average target implies a +142% move from current prices. That is up +2% on the projected 2033 average. Momentum favours further upside here.
The MLYS price prediction for 2035 points to an average of $68.49 (low $45.46, high $111.73) — a potential gain of +141% on today's $28.38. Buyers look set to stay in control over this stretch.
In 2040, MLYS is projected to trade between $67.00 and $189.86, averaging $108.94 — a potential gain of +284% from today's $28.38. That is up +59% on the projected 2035 average. Momentum favours further upside here.
Mineralys Therapeutics, Inc.'s 2050 outlook centres on $243.29, within a $131.00 to $466.56 range. That is up +123% on the projected 2040 average. That marks a +757% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in MLYS today (≈ 35.236082 MLYS) could be worth
$8,572.42
+$7,572.42 (+757%) by 2050 · US Dollar
Based on the average projected MLYS price of $243.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLYSwould be worth at today's price.
$1,000 invested in MLYS on Jul 10, 2025 (≈ 68.306009 MLYS) would be worth
$1,938.52
+$938.52 (+93.9%) today · 1.94× · US Dollar
Based on a MLYS entry price of $14.64 vs. today's $28.38.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.69 | $1,024.92 | +2.5% |
| 1 month ago | $23.76 | $1,194.44 | +19.4% |
| 3 months ago | $26.62 | $1,066.12 | +6.6% |
| 6 months ago | $32.98 | $860.52 | -13.9% |
| 1 year ago | $14.64 | $1,938.52 | +93.9% |
| All time (3.4y) ago | $18.44 | $1,539.05 | +53.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLYS forecast.
Our base-case forecast reaches $57.00 around 2032.
Implied market cap at $57.00: $5.03B
The multi-year forecast projects a bullish trajectory. For 2030 the avg is $44.08 with a min of $32.01 and a max of $65.61, yielding an ROI of 51.4 and a bullish sentiment. The 2040 forecast shows an avg of $115.24 with a min of $70.50 and a max of $201.71, yielding an ROI of 295.8 and a bullish sentiment.
By 2050 the avg is $257.50 with a min of $137.57 and a max of $496.30, yielding an ROI of 784.3 and a bullish sentiment.
These figures illustrate a strong long-term upward path, but they are estimates and not guarantees. Earlier years show continued growth (e.g., 2027 avg $33.53, 2028 avg $37.82, 2029 avg $41.59) alongside rising ROIs, underscoring the potential for significant upside alongside inherent investment uncertainty.
Tap a question to reveal the answer.
2030 forecast: avg $44.08, min $32.01, max $65.61; ROI 51.4; sentiment BULLISH.
Forecasts show rising averages over time (e.g., 2026 avg $29.12 to 2050 avg $257.50) with ROI reaching 784.3 by 2050, but these are estimates, not guarantees.
Yes. The forecast for 2040 shows an avg of $115.24 and a max of $201.71, indicating prices above $100 are projected.
Current price: $29.12. Market cap: $2.57B.
2050 forecast: avg $257.50, min $137.57, max $496.30; ROI 784.3; sentiment BULLISH.
Mineralys Therapeutics, Inc. Community Discussion
0Share your Mineralys Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.